Live from the NIH registry
Studies recruiting near Elk Grove right now
Top 25 of 633 recruiting studies, sorted by proximity — each links to its official registry page
Alternation in the Human Microbiome With Commonly Used Topical Medications
Healthy
Phase 1
Interventional 24 participants sought
University of California, Davis, Department of Dermatology — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
University of California - Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Abbott Medical Devices
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University of California Davis Health System — Sacramento, California (12.9 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
University of California, Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: Revolution Medicines, Inc.
Ivonescimab for the Treatment of Thymic Cancer
Thymus Carcinoma
Phase 2
Interventional 25 participants sought
University of California at Davis (UCD) — Davis, California (21.2 mi)
· Sponsor: Jonsson Comprehensive Cancer Center
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Metastatic Lobular Breast Carcinoma
Phase 1
Interventional 30 participants sought
University of California Davis — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Kaiser Permanente — Roseville, California (23.8 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Sutter Institute for Medical Research — Sacramento, California (12.9 mi)
· Sponsor: Medtronic MiniMed, Inc.
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Amyotrophic Lateral Sclerosis, Neuromuscular Disease
N/A
Interventional 2 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Paradromics
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of California Davis Comprehensive Cancer Center (Adults only) — Sacramento, California (12.9 mi)
· Sponsor: Pierre Fabre Medicament
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Sutter Medical Center Sacramento — Sacramento, California (12.9 mi)
· Sponsor: Children's Oncology Group
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
Trauma, Acute Pain
Phase 4
Interventional 156 participants sought
UC Davis Health — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
University of California, Davis, Department of Orthopedic Surgery — Sacramento, California (12.9 mi)
· Sponsor: International Spine Study Group Foundation
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10024 Sacramento, CA Investigational Site — Sacramento, California (12.9 mi)
· Sponsor: Colorado Prevention Center
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: NRG Oncology
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Clostridioides Difficile Infection
Phase 2
Interventional 230 participants sought
Research Site — Sacramento, California (12.9 mi)
· Sponsor: AstraZeneca
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
UC Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Mercy Cancer Center - Elk Grove — Elk Grove, California (0.8 mi)
· Sponsor: NRG Oncology
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retinal Consultants Med Group — Sacramento, California (12.9 mi)
· Sponsor: Genentech, Inc.
Nutrition for Precision Health, Powered by the All of Us
Nutrition, Health
N/A
Interventional 8,000 participants sought
University of California, Davis — Davis, California (21.2 mi)
· Sponsor: RTI International
The Ailliance Post-Market Clinical Study
Spinal Deformity, Spinal Degenerative Disorder
N/A
Interventional 1,000 participants sought
University of California Davis Medical Center — Sacramento, California (12.9 mi)
· Sponsor: Medtronic Spinal and Biologics
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Anarthria, Dysarthria
N/A
Interventional 2 participants sought
University of California, Davis — Sacramento, California (12.9 mi)
· Sponsor: Leigh R. Hochberg, MD, PhD.
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial
Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
N/A
Interventional 1,000 participants sought
University of California, Davis — Davis, California (21.2 mi)
· Sponsor: OHSU Knight Cancer Institute
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
Phase 2
Interventional 34 participants sought
University of California Davis Comprehensive Cancer Center — Sacramento, California (12.9 mi)
· Sponsor: University of California, Davis